Rexgenero appoints Liesbeth de Jong as Vice President, Manufacturing and R&D

04/01/2016

London, UK. Rexgenero Ltd appoints Liesbeth de Jong as Vice President, Manufacturing and R&D. Liesbeth brings extensive experience in cellular therapies at Novartis, Kiadis, Chronogen and in academic research.

innovative cell therapies
Contact us